These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 34041376)
1. The impact of Ramadan fasting on Fetuin-A level in type 2 diabetes mellitus. Harbuwono DS; Sazli BI; Kurniawan F; Darmowidjojo B; Koesnoe S; Tahapary DL Heliyon; 2021 May; 7(5):e06773. PubMed ID: 34041376 [TBL] [Abstract][Full Text] [Related]
2. Indonesia DIA-RAMADAN Study: A Real-life, Prospective and Observational of Gliclazide MR in Type-2 Diabetes Patients During Ramadan Fasting. Soelistijo SA; Aman AM; Zufry H; Pranoto A; Rudijanto A; Hassanien M Acta Med Indones; 2022 Jan; 54(1):3-9. PubMed ID: 35398820 [TBL] [Abstract][Full Text] [Related]
3. Effect of ramadan fasting on glycemic control and other essential variables in diabetic patients. Bener A; A Al-Hamaq AOA; Öztürk M; Çatan F; Haris PI; Rajput KU; Ömer A Ann Afr Med; 2018; 17(4):196-202. PubMed ID: 30588933 [TBL] [Abstract][Full Text] [Related]
4. The impact of fasting during Ramadan on the glycemic control of patients with type 2 diabetes mellitus. Sahin SB; Ayaz T; Ozyurt N; Ilkkilic K; Kirvar A; Sezgin H Exp Clin Endocrinol Diabetes; 2013 Oct; 121(9):531-4. PubMed ID: 23934679 [TBL] [Abstract][Full Text] [Related]
5. Ramadan Intermittent Fasting Affects Adipokines and Leptin/Adiponectin Ratio in Type 2 Diabetes Mellitus and Their First-Degree Relatives. Abdullah K; Al-Habori M; Al-Eryani E Biomed Res Int; 2020; 2020():1281792. PubMed ID: 32775407 [TBL] [Abstract][Full Text] [Related]
6. The impact of Ramadan fasting on glucose variability in type 2 diabetes mellitus patients on oral anti diabetic agents. Harbuwono DS; Kurniawan F; Sudarsono NC; Tahapary DL PLoS One; 2020; 15(6):e0234443. PubMed ID: 32598395 [TBL] [Abstract][Full Text] [Related]
7. A comparison of glycemic effects of glimepiride, repaglinide, and insulin glargine in type 2 diabetes mellitus during Ramadan fasting. Cesur M; Corapcioglu D; Gursoy A; Gonen S; Ozduman M; Emral R; Uysal AR; Tonyukuk V; Yilmaz AE; Bayram F; Kamel N Diabetes Res Clin Pract; 2007 Feb; 75(2):141-7. PubMed ID: 16815586 [TBL] [Abstract][Full Text] [Related]
8. Metabolic alterations as a result of Ramadan fasting in non-insulin-dependent diabetes mellitus patients in relation to food intake. Khatib FA; Shafagoj YA Saudi Med J; 2004 Dec; 25(12):1858-63. PubMed ID: 15711655 [TBL] [Abstract][Full Text] [Related]
9. The impact of Ramadan fasting on metabolic profile among type 2 diabetes mellitus patients: A meta-analysis. Tahapary DL; Astrella C; Kristanti M; Harbuwono DS; Soewondo P Diabetes Metab Syndr; 2020; 14(5):1559-1570. PubMed ID: 32947756 [TBL] [Abstract][Full Text] [Related]
10. Effect of Ramadan fasting on glycemic control in patients with Type 2 diabetes. Norouzy A; Mohajeri SM; Shakeri S; Yari F; Sabery M; Philippou E; Varasteh AR; Nematy M J Endocrinol Invest; 2012 Sep; 35(8):766-71. PubMed ID: 21986487 [TBL] [Abstract][Full Text] [Related]
11. Impact of provision of optimum diabetes care on the safety of fasting in Ramadan in adult and adolescent patients with type 1 diabetes mellitus. Alawadi F; Alsaeed M; Bachet F; Bashier A; Abdulla K; Abuelkheir S; Rashid F; Abdulaziz Bin Hussain A; Abdelgadir E; Alsayyah F; Elsayed M; Hassanein M Diabetes Res Clin Pract; 2020 Nov; 169():108466. PubMed ID: 32971155 [TBL] [Abstract][Full Text] [Related]
12. Glucometric parameter changes in patients with type 2 diabetes during ramadan fasting: A prospective comparative real-world study. Al Hayek A; Al Zahrani WM; Al Dawish MA Metabol Open; 2024 Sep; 23():100304. PubMed ID: 39175933 [TBL] [Abstract][Full Text] [Related]
13. Evaluating the impact of Ramadan fasting on ambulatory glucose profile among patients with type 1 diabetes using Flash Glucose Monitoring System: A comparative study. Al Hayek AA; Robert AA; Al Dawish MA Diabetes Metab Syndr; 2022 Apr; 16(4):102472. PubMed ID: 35366597 [TBL] [Abstract][Full Text] [Related]
14. Comparison of glycaemic control and anthropometric parameters before and after Ramadan fasting in a selected cohort of patients with type 2 diabetes mellitus in Sri Lanka. Shafras M; Monaragala L; Samarakkody I; Ahamed R; Nawarathna L; Sanas M; Antonypillai C Ceylon Med J; 2020 Dec; 65(4):79-85. PubMed ID: 34821486 [TBL] [Abstract][Full Text] [Related]
15. Differential effect of ramadan fasting on intercellular adhesion molecule-1 (ICAM-1) in diabetes mellitus and non-diabetes mellitus patients. Tahapary DL; Rizqa T; Syarira CV; Lusiani L; Rizka A; Wafa S; Wisnu W; Edi Tarigan TJ; Harbuwono DS Heliyon; 2023 Jul; 9(7):e17273. PubMed ID: 37455951 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of insulin glargine and glimepiride in subjects with Type 2 diabetes before, during and after the period of fasting in Ramadan. Salti I; Diabet Med; 2009 Dec; 26(12):1255-61. PubMed ID: 20002478 [TBL] [Abstract][Full Text] [Related]
17. Fasting during the holy month of Ramadan among older children and adolescents with type 1 diabetes in Kuwait. Mohamed K; Al-Abdulrazzaq D; Fayed A; El Busairi E; Al Shawaf F; Abdul-Rasoul M; Shaltout AA J Pediatr Endocrinol Metab; 2019 Aug; 32(8):843-849. PubMed ID: 31318694 [TBL] [Abstract][Full Text] [Related]
18. Impact of optimum diabetes care on the safety of fasting in Ramadan in adult patients with type 2 diabetes mellitus on insulin therapy. Bashier AMK; Hussain AKB; Alawadi F; Alsayyah F; Alsaeed M; Rashid F; Abdelgadir E; Bachet F; Abuelkheir S; Elsayed M; Hassanein M Diabetes Res Clin Pract; 2019 Apr; 150():301-307. PubMed ID: 30768940 [TBL] [Abstract][Full Text] [Related]
19. Correlation between pre-ramadan glycemic control and subsequent glucose fluctuation during fasting in adolescents with Type 1 diabetes. Afandi B; Kaplan W; Al Hassani N; Hadi S; Mohamed A J Endocrinol Invest; 2017 Jul; 40(7):741-744. PubMed ID: 28239763 [TBL] [Abstract][Full Text] [Related]
20. The use of Free Style Libre Continues Glucose Monitoring (FSL-CGM) to monitor the impact of Ramadan fasting on glycemic changes and kidney function in high-risk patients with diabetes and chronic kidney disease stage 3 under optimal diabetes care. Alawadi F; Rashid F; Bashier A; Abdelgadir E; Al Saeed M; Abuelkheir S; Khalifa A; Al Sayyah F; Bachet F; Elsayed M; Abdallah K; Hassanein M Diabetes Res Clin Pract; 2019 May; 151():305-312. PubMed ID: 30880094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]